In this case study scenario, the hand sanitiser will be supplied to the healthcare sector for use as either a surgical hand disinfectant or general hygienic hand rub in the provision of a health service. The product will be regulated as a New Low Risk Medicine by MEDSAFE and require consent from them before it can be supplied and marketed.
The landscape flow chart presented below is a representative example of the requirements, predominantly MEDSAFE, expected to apply throughout the pre-market life cycle (Scoping, Design, Development and Evaluation) of an antiseptic hand rub manufactured and supplied as a therapeutic good in New Zealand. After evaluation by MEDSAFE, and consent granted, the product can be supplied in New Zealand as a New Low Risk Medicine.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.